Both in Pharmaceuticals
Spero Therapeutics vs Gossamer Bio
Over the past year SPRO returned −36.8% and GOSS returned −94.9%; their daily moves had a correlation of -0.02.
SPRO −36.8% GOSS −94.9%Growth of $1, one year, split-adjusted
| Metric | SPRO | GOSS |
|---|---|---|
| Price | $1.20 | $11.58 |
| Market cap | $69.9M | $70.8M |
| Today | +0.84% | +0.52% |
| 1 month | 0.0% | −14.9% |
| 6 months | −46.4% | −54.8% |
| Year to date | −48.5% | −95.3% |
| 1 year | −36.5% | −94.6% |
| Revenue growth (YoY) | −100.0% | −19.6% |
| Gross margin | — | 100.0% |
| Net margin | — | 182.9% |
| P/E (TTM) | 9.5× | — |
| Price / sales | 1.5× | 1.3× |
| Net cash | $50.7M | $20.9M |
| Dividend yield | — | — |
| Volatility (60d) | 78.2% | 1,269.6% |
| Short % of float | 2.3% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).